Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The functions of EZH2 in immune cells: Principles for novel immunotherapies
Fang-Fei Shao, Bo-Jin Chen, Guoqing Wu
Journal of Leukocyte Biology (2020) Vol. 110, Iss. 1, pp. 77-87
Closed Access | Times Cited: 22

Showing 22 citing articles:

EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
Loretah Chibaya, Katherine Murphy, Kelly D. DeMarco, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 872-892
Open Access | Times Cited: 58
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Michał Woźniak, Małgorzata Czyż
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
H3K27me3-mediated regulation of PD-L1 expression in triple-negative breast cancer (TNBC)
J Harada, Kei Kawashima, Yuka Matsubara, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155872-155872
Closed Access
EZH2 Promotes T Follicular Helper Cell Differentiation Through Enhancing STAT3 Phosphorylation in Patients With Primary Sjögren’s Syndrome
Chengmei He, Yanlei Yang, Zhilei Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction
Sun Li, Xuefang Li, Hui Luo, et al.
Biochemical Pharmacology (2023) Vol. 213, pp. 115594-115594
Open Access | Times Cited: 5
Complex Cross-Talk between EZH2 and Mirnas Confers Hallmark Characteristics and Shapes the Tumor Microenvironment
Christopher Hillyar, Shivani Kanabar, Kathrine S Rallis, et al.
Epigenomics (2022) Vol. 14, Iss. 11, pp. 699-709
Open Access | Times Cited: 8
EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma
Shan Xu, Bohan Ma, Xiaoyu Feng, et al.
Translational Andrology and Urology (2023) Vol. 12, Iss. 1, pp. 71-82
Open Access | Times Cited: 4
RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma
Dandan Lu, Mijti Mihoayi, Yimin Ablikim, et al.
Aging (2024)
Open Access | Times Cited: 1
Novel insights into the dynamic function of PRC2 in innate immunity
Rosalie W.M. Kempkes, Rab K. Prinjha, Menno P.J. de Winther, et al.
Trends in Immunology (2024)
Open Access | Times Cited: 1
Histone methyltransferase Ezh2 negatively regulates NK cell terminal maturation and function
Minghang Yu, Ziyang Su, Xuefeng Huang, et al.
Journal of Leukocyte Biology (2021) Vol. 110, Iss. 6, pp. 1033-1045
Closed Access | Times Cited: 10
Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
Filipa D. dos Reis, Cármen Jerónimo, Margareta P. Correia
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation
DIVYA GANESH, Amal Dafar, Julia Niklasson, et al.
Anticancer Research (2023) Vol. 43, Iss. 4, pp. 1533-1542
Open Access | Times Cited: 2
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?
Andrea Casadei‐Gardini, Sara Lonardi, Valeria Smiroldo, et al.
Medical Oncology (2021) Vol. 38, Iss. 2
Closed Access | Times Cited: 4
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
Loretah Chibaya, Katherine Murphy, Yvette Lopez-Diaz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
The Role of Protein Methyltransferases in Immunity
Chaoran Song, Mi‐Yeon Kim, Jae Youl Cho
Molecules (2024) Vol. 29, Iss. 2, pp. 360-360
Open Access
Serum EZH2 protein levels are decreased in people with multiple sclerosis: A pilot study
Yasemin Ekmekyapar Fırat, Emine Kılıçparlar Cengiz, Elif Onur, et al.
Human Gene (2024) Vol. 40, pp. 201278-201278
Closed Access
Strategy against super-resistant bacteria: Curdlan-induced trained immunity combined with multi-epitope subunit vaccine
Hai Li, Lingdi Niu, Jiaqing Wang, et al.
International Journal of Biological Macromolecules (2024), pp. 135663-135663
Closed Access
EZH2 deletion does not impact acinar regeneration but restricts progression to pancreatic cancer in mice
Emilie Jaune, Xiaoyi Wang, Fatemeh Mousavi, et al.
JCI Insight (2024)
Open Access
Inhibition of EZH2 Causes Retrotransposon Derepression and Immune Activation in Porcine Lung Alveolar Macrophages
Liangliang Zhang, Jian Jin, Weiyun Qin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2394-2394
Open Access | Times Cited: 1
The Heightened Importance of EZH2 in Cancer Immunotherapy
Lin Xiaohu, Wenkai Zhou, Chengzhong Lin, et al.
Cancer Screening and Prevention (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1
EZH2i unlocks PDAC immune surveillance
Helene Damhofer, Kristian Helin
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 781-783
Closed Access | Times Cited: 1
EZH2 deletion does not impact acinar cell regeneration but restricts progression to pancreatic cancer in mice
Emilie Jaune, Xiaoyi Wang, Fatemeh Mousavi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top